Hem › Blåscancer › New York › Syracuse
Kliniska studier för Blåscancer i Syracuse, NY
4 studier för Blåscancer söker deltagare vid platser i och runt Syracuse (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RekryterarFas 1
- Upstate Specialty Services at Harrison Center, Syracuse
- SUNY Upstate Medical University, Syracuse
- SUNY Upstate Medical University-Community Campus, Syracuse
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RekryterarFas 2
- SUNY Upstate, Syracuse
- Associated Medical Professionals of NY, PLLC (US Urology Partners), Syracuse
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RekryterarFas 2
- Associated Medical Professionals of NY, PLLC, Syracuse
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekryterarFas 1/2
- Associated Medical Professionals of NY,, Syracuse
Blåscancer-studier i andra städer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Washington, DC26 studier
- Boston, MA26 studier
- Baltimore, MD24 studier
- Los Angeles, CA24 studier
- St. Louis, MO22 studier
- Seattle, WA21 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
Andra studier i Syracuse
- Icke-småcellig lungcancer15 studier
- Cancer (alla typer)9 studier
- Prostatacancer9 studier
- Icke-muskelinvasiv blåscancer8 studier
- Äggstockscancer7 studier
- Endometriecancer7 studier
- Övervikt6 studier
- Lungcancer6 studier
- Kolorektal cancer5 studier
- Makuladegeneration5 studier
- Akut myeloid leukemi5 studier
- Typ 2-diabetes5 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.